464 related articles for article (PubMed ID: 25510783)
1. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma.
Eldh M; Olofsson Bagge R; Lässer C; Svanvik J; Sjöstrand M; Mattsson J; Lindnér P; Choi DS; Gho YS; Lötvall J
BMC Cancer; 2014 Dec; 14():962. PubMed ID: 25510783
[TBL] [Abstract][Full Text] [Related]
2. Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T
Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
[TBL] [Abstract][Full Text] [Related]
3. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
6. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.
Ben-Shabat I; Hansson C; Sternby Eilard M; Cahlin C; Rizell M; Lindnér P; Mattsson J; Olofsson Bagge R
J Vis Exp; 2015 Jan; (95):52490. PubMed ID: 25650893
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.
Zuidervaart W; van der Velden PA; Hurks MH; van Nieuwpoort FA; Out-Luiting CJ; Singh AD; Frants RR; Jager MJ; Gruis NA
Br J Cancer; 2003 Nov; 89(10):1914-9. PubMed ID: 14612903
[TBL] [Abstract][Full Text] [Related]
8. Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
van Iersel LB; de Leede EM; Vahrmeijer AL; Tijl FG; den Hartigh J; Kuppen PJ; Hartgrink HH; Gelderblom H; Nortier JW; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2014 Nov; 40(11):1557-63. PubMed ID: 25125340
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
10. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
11. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.
Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P
Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
13. [Advances in uveal melanoma].
Piperno-Neumann S; Desjardins L
Rev Prat; 2014 Jan; 64(1):83-4. PubMed ID: 24649554
[No Abstract] [Full Text] [Related]
14. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver.
Noter SL; Rothbarth J; Pijl ME; Keunen JE; Hartgrink HH; Tijl FG; Kuppen PJ; van de Velde CJ; Tollenaar RA
Melanoma Res; 2004 Feb; 14(1):67-72. PubMed ID: 15091197
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
[TBL] [Abstract][Full Text] [Related]
16. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
17. Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial.
Olofsson R; Ny L; Eilard MS; Rizell M; Cahlin C; Stierner U; Lönn U; Hansson J; Ljuslinder I; Lundgren L; Ullenhag G; Kiilgaard JF; Nilsson J; Lindnér P
Trials; 2014 Aug; 15():317. PubMed ID: 25106493
[TBL] [Abstract][Full Text] [Related]
18. MR-guided laser-induced thermotherapy (LITT) in patients with liver metastases of uveal melanoma.
Eichler K; Zangos S; Gruber-Rouh T; Vogl TJ; Mack MG
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1756-60. PubMed ID: 24593299
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
[TBL] [Abstract][Full Text] [Related]
20. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
